CoChat

Subretinal Injection for Gene Therapy Does Not Cause Clinically Significant Outer Nuclear Layer Thinning in Normal Primate Foveae

Open access
Ochakovski, G. Alex, Peters, Tobias, Michalakis, Stylianos, Wilhelm, Barbara, Wissinger, Bernd, Biel, Martin, Bartz-Schmidt, K. Ulrich, Fischer, M. Dominik, for the RD-CURE Consortium · 2017 · Investigative Opthalmology & Visual Science

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

Purpose: Despite ever-growing adoption of subretinal (SRi) and intravitreal injections (IVTi) in ocular gene therapy trials, concerns regarding possible deleterious effects of the SRi on the outer retina are yet to be addressed. SRi offers several advantages over IVTi, such as a better photoreceptor transduction efficiency and a limited off-target exposure. We assessed structural changes in the outer retina in nonhuman primates following either SRi or IVTi of a gene therapeutic or control solution and compared both techniques in a noninferiority analysis. Methods: In a toxicology study, 22 cynomolgus monkeys underwent single intraocular injections with rAAV2/8 or vehicle; 18 animals received SRi, 4 animals received IVTi. Outer nuclear layer (ONL) thickness change on optical coherence tomography was used for a noninferiority analysis. Preservation of the physiological foveal bulge was used as a secondary outcome measure. Results: The average ONL change from baseline after 2 weeks was -6.54 ± 5.16 (mean ± SD μm) and +1.50 ± 4.36 for SRi and IVTi groups accordingly. At 13 weeks, the SRi group maintained a difference of -6.54 ± 9.66 while IVTi group gained +1.00 ± 4.24. The ellipsoid zone line was transiently lost after SRi and completely recovered by 13 weeks in 77% of eyes. One SRi case resulted in subfoveal pigment accumulation and 39% ONL thinning. Conclusions: Despite limited ONL thinning following SRi, the observed effect was under the predefined clinical significance threshold. The SRi has proven not to be inferior to the IVTi in terms of ONL thickness loss and estimated loss of visual acuity.

Overview

Integrity signals

Registry

Crossref · 10.1167/iovs.17-22402

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 39

Metadata

Authors
Ochakovski, G. A., Peters, T., Michalakis, S., Wilhelm, B., Wissinger, B., Biel, M., Bartz-Schmidt, K. U., Fischer, M. D., & for the RD-CURE Consortium
Affiliations
  • Universitätsklinikum Tübingen (DE)
  • Center for Integrated Protein Science Munich (DE)
  • University Eye Hospital, Centre for Ophthalmology, University Hospital Tübingen, Tübingen, Germany
  • University of Oxford (GB)
Corresponding author
Fischer, M. Dominik
Venue
Investigative Opthalmology & Visual Science
Published
2017-08-22
Volume
58
Issue
10
Pages
4155
ISSN
  • 0146-0404 (ISSN-L)
  • 1552-5783
OpenAlex
W2746908999
Cited by
38
References
29
Citations by year
2026: 3 · 2025: 2 · 2024: 2 · 2023: 3 · 2022: 8 · 2021: 3 · 2020: 4 · 2019: 5 · 2018: 6 · 2017: 2
FWCI
1.90
Type
journal article
Language
en
Open access
Locations
  • Investigative Ophthalmology & Visual Science (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Korea University Business School
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Keywords
subretinal injection, intravitreal injection, ocular gene therapy, outer nuclear layer thinning, Macaca fascicularis, ellipsoid zone, non-inferiority
MeSH terms
Animals, Female, Fovea Centralis, Macaca fascicularis, Male, Retina, Visual Acuity, Genetic Therapy, Photoreceptor Cells, Vertebrate, Tomography, Optical Coherence, Retinal Pigment Epithelium, Injections, Intraocular, Intravitreal Injections

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.